vs
FGI Industries Ltd.（FGI）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
FGI Industries Ltd.的季度营收约是STANDARD BIOTOOLS INC.的1.6倍（$30.5M vs $19.6M），FGI Industries Ltd.净利率更高（-8.6% vs -177.4%，领先168.8%），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -14.4%），FGI Industries Ltd.自由现金流更多（$2.3M vs $-23.1M），过去两年FGI Industries Ltd.的营收复合增速更高（-0.5% vs -12.2%）
FGI Industries Ltd是一家全球厨卫产品、家居收纳解决方案及家装用品的设计、制造与分销商，服务覆盖北美、欧洲及亚太地区的大型连锁零售商、家居专营店和电商平台。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
FGI vs LAB — 直观对比
营收规模更大
FGI
是对方的1.6倍
$19.6M
营收增速更快
LAB
高出2.9%
-14.4%
净利率更高
FGI
高出168.8%
-177.4%
自由现金流更多
FGI
多$25.4M
$-23.1M
两年增速更快
FGI
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.5M | $19.6M |
| 净利润 | $-2.6M | $-34.7M |
| 毛利率 | 26.7% | 48.5% |
| 营业利润率 | -2.2% | -168.5% |
| 净利率 | -8.6% | -177.4% |
| 营收同比 | -14.4% | -11.5% |
| 净利润同比 | -553.1% | -28.8% |
| 每股收益（稀释后） | $-1.63 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FGILAB
| Q4 25 | $30.5M | — | ||
| Q3 25 | $35.8M | $19.6M | ||
| Q2 25 | $31.0M | $21.8M | ||
| Q1 25 | $33.2M | $40.8M | ||
| Q4 24 | $35.6M | — | ||
| Q3 24 | $36.1M | $22.1M | ||
| Q2 24 | $29.4M | $22.5M | ||
| Q1 24 | $30.8M | $45.5M |
净利润FGILAB
| Q4 25 | $-2.6M | — | ||
| Q3 25 | $-1.7M | $-34.7M | ||
| Q2 25 | $-1.2M | $-33.5M | ||
| Q1 25 | $-629.1K | $-26.0M | ||
| Q4 24 | $-402.3K | — | ||
| Q3 24 | $-550.1K | $-26.9M | ||
| Q2 24 | $163.6K | $-45.7M | ||
| Q1 24 | $-412.2K | $-32.2M |
毛利率FGILAB
| Q4 25 | 26.7% | — | ||
| Q3 25 | 26.5% | 48.5% | ||
| Q2 25 | 28.1% | 48.8% | ||
| Q1 25 | 26.8% | 48.4% | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 25.8% | 54.9% | ||
| Q2 24 | 30.5% | 46.1% | ||
| Q1 24 | 27.4% | 53.1% |
营业利润率FGILAB
| Q4 25 | -2.2% | — | ||
| Q3 25 | 1.0% | -168.5% | ||
| Q2 25 | -2.7% | -118.1% | ||
| Q1 25 | -3.9% | -80.8% | ||
| Q4 24 | -3.5% | — | ||
| Q3 24 | -0.2% | -120.9% | ||
| Q2 24 | -1.5% | -134.5% | ||
| Q1 24 | -1.0% | -132.2% |
净利率FGILAB
| Q4 25 | -8.6% | — | ||
| Q3 25 | -4.6% | -177.4% | ||
| Q2 25 | -4.0% | -153.7% | ||
| Q1 25 | -1.9% | -63.8% | ||
| Q4 24 | -1.1% | — | ||
| Q3 24 | -1.5% | -122.0% | ||
| Q2 24 | 0.6% | -203.3% | ||
| Q1 24 | -1.3% | -70.6% |
每股收益（稀释后）FGILAB
| Q4 25 | $-1.63 | — | ||
| Q3 25 | $-0.86 | $-0.09 | ||
| Q2 25 | $-0.64 | $-0.09 | ||
| Q1 25 | $-0.07 | $-0.07 | ||
| Q4 24 | $-0.38 | — | ||
| Q3 24 | $-0.29 | $-0.07 | ||
| Q2 24 | $0.08 | $-0.12 | ||
| Q1 24 | $-0.04 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.9M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $17.3M | $399.7M |
| 总资产 | $69.5M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FGILAB
| Q4 25 | $1.9M | — | ||
| Q3 25 | $1.9M | $129.4M | ||
| Q2 25 | $2.5M | $158.6M | ||
| Q1 25 | $1.2M | $150.9M | ||
| Q4 24 | $4.6M | — | ||
| Q3 24 | $3.0M | $210.6M | ||
| Q2 24 | $1.3M | $269.8M | ||
| Q1 24 | $3.3M | $287.1M |
总债务FGILAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益FGILAB
| Q4 25 | $17.3M | — | ||
| Q3 25 | $19.7M | $399.7M | ||
| Q2 25 | $21.3M | $424.5M | ||
| Q1 25 | $21.8M | $454.6M | ||
| Q4 24 | $22.3M | — | ||
| Q3 24 | $23.5M | $489.3M | ||
| Q2 24 | $23.8M | $510.3M | ||
| Q1 24 | $23.9M | $577.3M |
总资产FGILAB
| Q4 25 | $69.5M | — | ||
| Q3 25 | $73.0M | $539.6M | ||
| Q2 25 | $71.7M | $557.0M | ||
| Q1 25 | $68.5M | $579.6M | ||
| Q4 24 | $75.5M | — | ||
| Q3 24 | $74.7M | $681.5M | ||
| Q2 24 | $69.9M | $708.7M | ||
| Q1 24 | $68.6M | $777.7M |
负债/权益比FGILAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.3M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $2.3M | $-23.1M |
| 自由现金流率自由现金流/营收 | 7.5% | -118.1% |
| 资本支出强度资本支出/营收 | 0.2% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-212.5K | $-111.1M |
8季度趋势，按日历期对齐
经营现金流FGILAB
| Q4 25 | $2.3M | — | ||
| Q3 25 | $-1.9M | $-22.2M | ||
| Q2 25 | $7.6M | $-20.7M | ||
| Q1 25 | $-7.4M | $-30.3M | ||
| Q4 24 | $617.4K | — | ||
| Q3 24 | $-915.0K | $-27.9M | ||
| Q2 24 | $862.1K | $-39.0M | ||
| Q1 24 | $-8.0M | $-62.5M |
自由现金流FGILAB
| Q4 25 | $2.3M | — | ||
| Q3 25 | $-2.1M | $-23.1M | ||
| Q2 25 | $7.4M | $-22.6M | ||
| Q1 25 | $-7.7M | $-35.3M | ||
| Q4 24 | $-214.1K | — | ||
| Q3 24 | $-1.1M | $-30.1M | ||
| Q2 24 | $281.5K | $-41.0M | ||
| Q1 24 | $-8.6M | $-63.3M |
自由现金流率FGILAB
| Q4 25 | 7.5% | — | ||
| Q3 25 | -5.9% | -118.1% | ||
| Q2 25 | 23.8% | -103.6% | ||
| Q1 25 | -23.3% | -86.6% | ||
| Q4 24 | -0.6% | — | ||
| Q3 24 | -3.0% | -136.4% | ||
| Q2 24 | 1.0% | -182.2% | ||
| Q1 24 | -28.0% | -138.9% |
资本支出强度FGILAB
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.7% | 4.5% | ||
| Q2 25 | 0.7% | 8.7% | ||
| Q1 25 | 1.1% | 12.4% | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 0.5% | 10.2% | ||
| Q2 24 | 2.0% | 8.6% | ||
| Q1 24 | 2.0% | 1.7% |
现金转化率FGILAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.27× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
